EMERGENT BIOSOLUTI revenue breakdown overview

EMERGENT BIOSOLUTI revenue for the last year amounted to 947.80 M CHF, the most of which — 463.00 M CHF — came from its highest performing source at the moment, Medical Countermeasures Products, the year earlier bringing 376.51 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought EMERGENT BIOSOLUTI 747.08 M CHF, and the year before that — 511.22 M CHF.